Featured Research

from universities, journals, and other organizations

New Calculator Provides More Accurate Estimates Of Colon Cancer Survival

Date:
April 6, 2004
Source:
Mayo Clinic
Summary:
A new calculator tool can help physicians provide colon cancer patients with more accurate, individualized five-year disease-free and overall survival estimates with surgery alone and with additional chemotherapy treatment.

ROCHESTER, Minn. -- A new calculator tool can help physicians provide colon cancer patients with more accurate, individualized five-year disease-free and overall survival estimates with surgery alone and with additional chemotherapy treatment.

Related Articles


The calculator tool was developed by an international team of researchers, co-led by Charles Loprinzi, M.D., and Sharlene Gill, M.D. Dr. Loprinzi is a medical oncologist at Mayo Clinic and program leader of the Cancer Control Program for Mayo Clinic Cancer Center in Rochester, Minn.; Dr. Gill is at the British Columbia Cancer Center in Vancouver, Canada.

The report explaining the tool, entitled "Pooled Analysis of Fluorouracil-Based Adjuvant Chemotherapy for Stage II and III Colon Cancer: Who Benefits and by How Much," will be published April 5 on the Internet site of the Journal of Clinical Oncology, http://www.jco.org.

"Most newly-diagnosed cancer patients consistently report that they want information about their likelihood of a cure, and most prefer both qualitative and quantitative information when making decisions about their course of treatment," says Dr. Loprinzi. "At the same time, variations and uncertainty exist when estimating prognoses for cancer patients. As a result, patients may not get the information they want, or they may misunderstand the risks of their disease and the reasons for considering the use of chemotherapy after colon cancer surgery."

Previously conducted clinical trials have clearly demonstrated that chemotherapy after surgery can improve cure rates for various groups of patients with colon cancer.

"Our intent with this calculator is to help clarify the situation by providing physicians with a tool for more accurately estimating a colon cancer patient's prognosis," says Dr. Gill. "Physicians can then use this information as appropriate to help their patients make more informed decisions about an individual patient's probability of being cured of stage II or III colon cancer through surgery alone, and how much chemotherapy after surgery will improve their chances of staying free of recurrent colon cancer."

An estimated 106,000 people in the United States will be diagnosed with colon cancer this year. About 60,000 of those patients may be candidates for adjuvant chemotherapy after surgery.

The computer program used by the calculator is based on pooled data from 3,302 patients who had surgically-resected stage II and III colon cancer and had participated in one of seven different clinical trials. All of these patients had all known cancer removed by surgery.

However, each was considered at substantial enough risk for recurrent colon cancer to warrant participating in a clinical trial to test whether additional treatment might increase the chance of cure. The patients were randomly assigned to no further treatment or to receive chemotherapy consisting of fluorouracil (5-FU) with leucovorin or with levamisole.

To use the calculator, physicians enter information about four factors that impact treatment options and prognosis: 1) The number of positive, or cancer-affected, lymph nodes, 2) The depth of the tumor through the bowel wall, 3) The grade of the tumor (determined by looking at the cancer under the microscope), and 4) The age of the patient. The calculator then computes the chances of the colon cancer not returning and of the patient being alive five years after treatment, both with surgery alone and with surgery plus adjuvant chemotherapy treatment.

An example of a reasonably favorable outcome involving adjuvant chemotherapy after surgery for colon cancer includes the following:

Information entered: Number of positive lymph nodes -- No positive nodes
Depth of tumor (T stage) -- T3
Grade of tumor -- Low
Age -- 49 or younger

Information generated by the computerized calculator:
* Five-year recurrence-free survival:
Baseline prognosis with surgery alone -- 73%
Prognosis with surgery and adjuvant 5-FU -- 77%
* Five-year overall survival:
Baseline prognosis with surgery alone -- 83%
Prognosis with surgery and adjuvant 5-FU -- 85%

An example of a less favorable outcome includes the following:

Information entered:
Number of positive lymph nodes -- 5 or more
Depth of tumor (T stage) -- T3
Grade of tumor -- Low
Age of patient -- 49 or younger

Information generated by the computerized calculator:
* Five-year recurrence-free survival:
Baseline prognosis with surgery alone -- 24%
Prognosis with surgery and adjuvant 5-FU -- 43%
* Five-year overall survival:
Baseline prognosis with surgery alone -- 40%
Prognosis with surgery and adjuvant 5-FU -- 56%

According to Dr. Loprinzi, the calculator may be modified as new prognostic information and as data about additional benefits from newer adjuvant chemotherapy regimens become available.

For instance, he says, "If a physician is convinced that a newer chemotherapy regimen is more beneficial than the ones studied in the randomized clinical trials we reviewed, then appropriate data can be entered into the calculator to individualize estimates for patients."

Dr. Loprinzi emphasized that this calculator is intended only for estimates of survival. "It is an aid for making decisions about adjuvant chemotherapy treatment, and, as with all prognostic tools, the information is to be interpreted within the context of the individual patient's situation by the patient's oncologist."

This is the third such calculator developed by Dr. Loprinzi and research colleagues; similar tools have been created for estimating outcomes for patients diagnosed with breast cancer and melanoma.

###

To obtain the latest news releases from Mayo Clinic, go to http://www.mayoclinic.org/news. MayoClinic.com (http://www.mayoclinic.com) is available as a resource for your health stories.

Cancer researchers working with Dr. Loprinzi and Dr. Gill to develop this calculator included: Daniel J. Sargent, Ph.D., Mayo Clinic; Stephan Thomé, M.D., Ph.D., Creighton University, Omaha, Neb.; Steven Alberts, M.D., Mayo Clinic; Daniel Haller, University of Pennsylvania Cancer Center in Philadelphia; Lois Shepherd, Ph.D., National Cancer Institute of Canada-Clinical Trials Group, Queens University in Kingston, Ontario; Jacqueline Benedetti,Ph.D., Southwest Oncology Group Statistical Center in Seattle, Wash.; Guido Francini, M.D., University of Siena, Siena, Italy; Jean Francois Seitz, University of the Mediterranean, Marseilles, France; Roberto Labianca, Ph.D., Ospedali Riuniti, Bergamo, Italy; Wei Chen, Mayo Clinic; Stephen Cha, Mayo Clinic; Michael Heldebrant, Mayo Clinic; and Richard Goldberg, M.D., University of North Carolina, Chapel Hill, N.C.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "New Calculator Provides More Accurate Estimates Of Colon Cancer Survival." ScienceDaily. ScienceDaily, 6 April 2004. <www.sciencedaily.com/releases/2004/04/040406085118.htm>.
Mayo Clinic. (2004, April 6). New Calculator Provides More Accurate Estimates Of Colon Cancer Survival. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2004/04/040406085118.htm
Mayo Clinic. "New Calculator Provides More Accurate Estimates Of Colon Cancer Survival." ScienceDaily. www.sciencedaily.com/releases/2004/04/040406085118.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins